UBE Microdiscectomy Beneficial for Lumbar Disc Herniation
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- For adults with symptomatic lumbar disc herniation, unilateral biportal endoscopic (UBE) microdiscectomy is associated with longer operating times and with lower pain medication consumption in the early postoperative period compared with tubular lumbar microdiscectomy, according to a study published online Sept. 19 in Blood.
Charla Fischer, M.D., from NYU Langone Health in New York City, and colleagues examined surgical outcomes and pain medication consumption for UBE versus tubular lumbar microdiscectomy in a retrospective cohort study of adults undergoing primary, single-level UBE or tubular lumbar microdiscectomy surgery at a high-volume institution. Data were included for 102 patients: 48 undergoing UBE and 54 tubular lumbar microdiscectomy.
The researchers found that the average operative time was higher for UBE than for tubular patients (133.1 versus 86.6 minutes), which trended downward over time but did not reach statistical significance. Complication or reoperation rates did not differ. From discharge to two-week follow-up, the average daily morphine milligram equivalents were lower in the UBE group (11.1 versus 14.1) but were similar thereafter. The UBE cohort had lower nonopioid medication prescription from discharge to two weeks (70.8 versus 92.6 percent) and two to six weeks (52.1 versus 85.2 percent), with no significant differences seen thereafter.
"This breakthrough technique is a game changer because it gives patients a better recovery with less pain and less need for narcotics and their related side-effects," Fischer said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 06:00
Read more
- Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)
- ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
- Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- 2008 to 2020 Saw More Radiologists Involved in Teaching
- Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer
- Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions